Abstract
Circulating extracellular matrix (ECM) proteins are serological biomarkers of interest due to their association with pathologies involving disease processes such as fibrosis and cancers. In this study, we investigate the potential for serum biomarker research using differential protease specificity (DPS), leveraging alternate protease specificity as a targeting mechanism to selectively digest circulating ECM protein serum proteins. A proof-of-concept study is presented using serum from patients with cirrhotic liver or hepatocellular carcinoma. The approach uses collagenase DPS for digestion of deglycosylated serum and liquid-chromatography-trapped ion mobility-tandem mass spectrometry (LC-TIMS-MS/MS) to enhance the detection of ECM proteins in serum. It requires no sample enrichment and minimizes the albumin average precursor intensity readout to less than 1.2%. We further demonstrate the capabilities for using the method as a high-throughput matrix-assisted laser/desorption ionization mass spectrometry (MALDI-MS) assay coupled with reference library searching. A goal is to improve the depth and breadth of biofluid proteomics for noninvasive assays.
Original language | English |
---|---|
Pages (from-to) | 487-497 |
Number of pages | 11 |
Journal | Journal of the American Society for Mass Spectrometry |
Volume | 35 |
Issue number | 3 |
DOIs | |
State | Published - Mar 6 2024 |
Externally published | Yes |
Funding
J.K.M. was supported by the Cellular, Biochemical and Molecular Sciences Training Program 5T32GM132055 (NIH/NIGMS). P.M.A. was supported by NIH/NCI R21CA263464, R01CA253460; and in part by pilot research funding, Hollings Cancer Center’s Cancer Center Support Grant P30 CA138313 at the Medical University of South Carolina. Supported in part by MUSC Digestive Disease Research Core Center (P30DK123794) and the Biorepository & Tissue Analysis Shared Resource and the Translational Science Laboratory, Hollings Cancer Center, Medical University of South Carolina. The FT was supported by the provost office and Hollings Cancer Center. Additional support was provided by the South Carolina Centers of Economic Excellence SmartState program to RRD and ASM. The Mass Spectrometry Facility and Redox Proteomics Core is supported by the University and P20GM103542 (NIH/NIGMS) with shared instrumentation S10 OD010731 & S10 OD025126 (NIH/OD) to LEB and S10 0D030212 to PMA. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or NCATS.
Funders | Funder number |
---|---|
Hollings Cancer Center’s Cancer Center | P30 CA138313 |
MUSC Digestive Disease Research Core Center | P30DK123794 |
NIH/OD | S10 0D030212 |
South Carolina Centers | |
Translational Science Laboratory | |
University | P20GM103542, S10 OD025126 |
National Institutes of Health | |
National Cancer Institute | R01CA253460, R21CA263464 |
National Institute of General Medical Sciences | |
National Center for Advancing Translational Sciences | |
Hollings Cancer Center, Medical University of South Carolina | |
Medical University of South Carolina |
Keywords
- collagen
- extracellular matrix
- proteomics
- serum
- trapped ion mobility